05232017Headline:

Emerging Markets Such As China and India Offer High Growth Opportunities for Major Players in the Bone Growth Stimulators Market

The major factors driving the growth of the bone growth stimulators market are growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments. In this report, the market has been segmented by product, end user, application, and region.

In 2016, North America held the largest share of the market. However, the developing Asia-Pacific countries including China and India are expected to emerge as the new revenue-generating regions for prominent market players during 2017-2022. The growth of the Asia-Pacific market is attributed to the presence of a large patient population for target diseases (coupled with rapidly growing geriatric population, especially in Japan and China), growing awareness of novel and upcoming orthopedic treatment options among healthcare professionals, and ongoing government initiatives to modernize & expand healthcare infrastructure.

Based on product, the market is segmented into bone growth stimulation devices, bone morphogenetic protein (BMPs), and platelet-rich plasma (PRP). The platelet-rich plasma (PRP) segment is projected to be the fastest growing segment during the forecast period. This growth can primarily be attributed to the increasing use of PRP in sports injuries and the expansion of its applications (due to a growing number of clinical trials).

On the basis of application, the market is segmented into spinal fusion surgeries, delayed union and nonunion bone fractures, oral and maxillofacial surgeries, and other applications. The spinal fusion surgeries segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the growing geriatric population, rising number of spine procedures (and rate of spinal fusion failure), established safety and efficacy of stimulators in fusion surgery, and increasing use of bone growth stimulation products.

By end user, the market is segmented into hospitals & clinics, home care, and academic & research institutes and CROs. The hospitals & clinics segment is expected to grow at the highest CAGR during the forecast period. The advantage of bone growth stimulation products over their counterparts is the key factor driving their adoption in this end-user segment.

What Next?

Recent Articles